No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.
Petrazzuolo A, Le Naour J, Vacchelli E, Gaussem P, Ellouze S, Jourdi G, Solary E, Fontenay M, Smadja DM, Kroemer G.
Petrazzuolo A, et al. Among authors: jourdi g.
Oncoimmunology. 2020 Dec 8;9(1):1857112. doi: 10.1080/2162402X.2020.1857112.
Oncoimmunology. 2020.
PMID: 33344044
Free PMC article.